exxeladmin, Author at Exxel Pharma

Exxel Pharma Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
Exxel Pharma’s Innovative Small Molecule, EX937, Rapidly Advancing Toward First-In-Human Study for the Treatment of Refractory Chronic Cough
Exxel Pharma to Participate in a “New to Virtual Investor” Segment
Exxel’s CSO Daniele Piomelli receives Entrepreneurial Leader of the Year award from UC Irvine (UCI) Beall Applied Innovation
NEW YORK TIMES: At 71, She’s Never Felt Pain or Anxiety. Now Scientists Know Why.
University of Malta scientists speak of ‘safe way to block seizures with endocannabinoids’
Harnessing brain’s internal reserves might help treat epilepsy
Daniele Piomelli and Bob Solomon: Why we need pot research